Cargando…

Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone

Maintenance of physiologic phosphate balance is of crucial biological importance, as it is fundamental to cellular function, energy metabolism, and skeletal mineralization. Fibroblast growth factor-23 (FGF-23) is a master regulator of phosphate homeostasis, but the molecular mechanism of such regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Sitara, Despina, Kim, Somi, Razzaque, Mohammed S., Bergwitz, Clemens, Taguchi, Takashi, Schüler, Christiane, Erben, Reinhold G., Lanske, Beate
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483943/
https://www.ncbi.nlm.nih.gov/pubmed/18688277
http://dx.doi.org/10.1371/journal.pgen.1000154
_version_ 1782158075278393344
author Sitara, Despina
Kim, Somi
Razzaque, Mohammed S.
Bergwitz, Clemens
Taguchi, Takashi
Schüler, Christiane
Erben, Reinhold G.
Lanske, Beate
author_facet Sitara, Despina
Kim, Somi
Razzaque, Mohammed S.
Bergwitz, Clemens
Taguchi, Takashi
Schüler, Christiane
Erben, Reinhold G.
Lanske, Beate
author_sort Sitara, Despina
collection PubMed
description Maintenance of physiologic phosphate balance is of crucial biological importance, as it is fundamental to cellular function, energy metabolism, and skeletal mineralization. Fibroblast growth factor-23 (FGF-23) is a master regulator of phosphate homeostasis, but the molecular mechanism of such regulation is not yet completely understood. Targeted disruption of the Fgf-23 gene in mice (Fgf-23(−/−)) elicits hyperphosphatemia, and an increase in renal sodium/phosphate co-transporter 2a (NaPi2a) protein abundance. To elucidate the pathophysiological role of augmented renal proximal tubular expression of NaPi2a in Fgf-23(−/−) mice and to examine serum phosphate–independent functions of Fgf23 in bone, we generated a new mouse line deficient in both Fgf-23 and NaPi2a genes, and determined the effect of genomic ablation of NaPi2a from Fgf-23(−/−) mice on phosphate homeostasis and skeletal mineralization. Fgf-23(−/−)/NaPi2a(−/−) double mutant mice are viable and exhibit normal physical activities when compared to Fgf-23(−/−) animals. Biochemical analyses show that ablation of NaPi2a from Fgf-23(−/−) mice reversed hyperphosphatemia to hypophosphatemia by 6 weeks of age. Surprisingly, despite the complete reversal of serum phosphate levels in Fgf-23(−/−)/NaPi2a(−/−), their skeletal phenotype still resembles the one of Fgf23(−/−) animals. The results of this study provide the first genetic evidence of an in vivo pathologic role of NaPi2a in regulating abnormal phosphate homeostasis in Fgf-23(−/−) mice by deletion of both NaPi2a and Fgf-23 genes in the same animal. The persistence of the skeletal anomalies in double mutants suggests that Fgf-23 affects bone mineralization independently of systemic phosphate homeostasis. Finally, our data support (1) that regulation of phosphate homeostasis is a systemic effect of Fgf-23, while (2) skeletal mineralization and chondrocyte differentiation appear to be effects of Fgf-23 that are independent of phosphate homeostasis.
format Text
id pubmed-2483943
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-24839432008-08-08 Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone Sitara, Despina Kim, Somi Razzaque, Mohammed S. Bergwitz, Clemens Taguchi, Takashi Schüler, Christiane Erben, Reinhold G. Lanske, Beate PLoS Genet Research Article Maintenance of physiologic phosphate balance is of crucial biological importance, as it is fundamental to cellular function, energy metabolism, and skeletal mineralization. Fibroblast growth factor-23 (FGF-23) is a master regulator of phosphate homeostasis, but the molecular mechanism of such regulation is not yet completely understood. Targeted disruption of the Fgf-23 gene in mice (Fgf-23(−/−)) elicits hyperphosphatemia, and an increase in renal sodium/phosphate co-transporter 2a (NaPi2a) protein abundance. To elucidate the pathophysiological role of augmented renal proximal tubular expression of NaPi2a in Fgf-23(−/−) mice and to examine serum phosphate–independent functions of Fgf23 in bone, we generated a new mouse line deficient in both Fgf-23 and NaPi2a genes, and determined the effect of genomic ablation of NaPi2a from Fgf-23(−/−) mice on phosphate homeostasis and skeletal mineralization. Fgf-23(−/−)/NaPi2a(−/−) double mutant mice are viable and exhibit normal physical activities when compared to Fgf-23(−/−) animals. Biochemical analyses show that ablation of NaPi2a from Fgf-23(−/−) mice reversed hyperphosphatemia to hypophosphatemia by 6 weeks of age. Surprisingly, despite the complete reversal of serum phosphate levels in Fgf-23(−/−)/NaPi2a(−/−), their skeletal phenotype still resembles the one of Fgf23(−/−) animals. The results of this study provide the first genetic evidence of an in vivo pathologic role of NaPi2a in regulating abnormal phosphate homeostasis in Fgf-23(−/−) mice by deletion of both NaPi2a and Fgf-23 genes in the same animal. The persistence of the skeletal anomalies in double mutants suggests that Fgf-23 affects bone mineralization independently of systemic phosphate homeostasis. Finally, our data support (1) that regulation of phosphate homeostasis is a systemic effect of Fgf-23, while (2) skeletal mineralization and chondrocyte differentiation appear to be effects of Fgf-23 that are independent of phosphate homeostasis. Public Library of Science 2008-08-08 /pmc/articles/PMC2483943/ /pubmed/18688277 http://dx.doi.org/10.1371/journal.pgen.1000154 Text en Sitara et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Sitara, Despina
Kim, Somi
Razzaque, Mohammed S.
Bergwitz, Clemens
Taguchi, Takashi
Schüler, Christiane
Erben, Reinhold G.
Lanske, Beate
Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
title Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
title_full Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
title_fullStr Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
title_full_unstemmed Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
title_short Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on Bone
title_sort genetic evidence of serum phosphate-independent functions of fgf-23 on bone
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483943/
https://www.ncbi.nlm.nih.gov/pubmed/18688277
http://dx.doi.org/10.1371/journal.pgen.1000154
work_keys_str_mv AT sitaradespina geneticevidenceofserumphosphateindependentfunctionsoffgf23onbone
AT kimsomi geneticevidenceofserumphosphateindependentfunctionsoffgf23onbone
AT razzaquemohammeds geneticevidenceofserumphosphateindependentfunctionsoffgf23onbone
AT bergwitzclemens geneticevidenceofserumphosphateindependentfunctionsoffgf23onbone
AT taguchitakashi geneticevidenceofserumphosphateindependentfunctionsoffgf23onbone
AT schulerchristiane geneticevidenceofserumphosphateindependentfunctionsoffgf23onbone
AT erbenreinholdg geneticevidenceofserumphosphateindependentfunctionsoffgf23onbone
AT lanskebeate geneticevidenceofserumphosphateindependentfunctionsoffgf23onbone